Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

3755studies shown

Showing 181-192 of 3,755

Drug study icon

RecruitingNCT07610473

Effectiveness of DT-101 in depression

The registry lists this study as recruiting. Study locations are listed in the United States.

Multiple locations, including Phoenix

DepressionDrugFrom 18 Years to 75 Years

Countries: United States
Sponsor: Draig Therapeutics Ltd
Condition: Depression

Drug study icon

RecruitingNCT07300969

Effectiveness of DT-101 in depression

The registry lists this study as recruiting. Study locations are listed in the United States, in the United Kingdom, in Bulgaria, ...

Multiple locations, including Bentonville

DepressionDrugFrom 18 Years to 75 Years

Countries: United States, United Kingdom, Bulgaria, ...
Sponsor: Draig Therapeutics Ltd
Condition: Depression

Drug study icon

RecruitingNCT07105111

Effectiveness of valbenazine in adults with tardive dyskinesia

The registry lists this study as recruiting. Study locations are listed in the United States.

Multiple locations, including Bryant

Schizophrenia, Depression, ...DrugOver 18 Years

Countries: United States
Sponsor: Neurocrine Biosciences
Condition: Schizophrenia, Depression, ...

Behavioral study icon

RecruitingNCT07380412

Effects of a Supplement on the Side Effects Associated With Stimulant Medications

The registry lists this study as recruiting. Study locations are listed in the United States.

In Las Vegas

ADHDBehavioralFrom 18 Years to 55 Years

Countries: United States
Sponsor: Outliers, Inc.
Condition: ADHD

Drug study icon

RecruitingNCT07140913

KarXT for manic episodes in bipolarity type I

The registry lists this study as recruiting. Study locations are listed in the United States, in France, in Argentina, ...

Multiple locations, including Bentonville

BipolarityDrugFrom 18 Years to 65 Years

Countries: United States, France, Argentina, ...
Sponsor: Bristol-Myers Squibb
Condition: Bipolarity

Drug study icon

RecruitingNCT07227454

Esketamine for depression

The registry lists this study as recruiting. Study locations are listed in the United States, in Brazil, in Hungary, ...

Multiple locations, including Birmingham

DepressionDrugFrom 12 Years to 17 Years

Countries: United States, Brazil, Hungary, ...
Sponsor: Janssen Research & Development, LLC
Condition: Depression

Drug study icon

RecruitingNCT06951698

KarXT for manic episodes in bipolarity type I

The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in New Zealand, ...

Multiple locations, including Little Rock

BipolarityDrugFrom 18 Years to 65 Years

Countries: United States, Australia, New Zealand, ...
Sponsor: Bristol-Myers Squibb
Condition: Bipolarity

Drug study icon

RecruitingNCT06951711

KarXT for manic episodes in bipolarity type I

The registry lists this study as recruiting. Study locations are listed in the United States, in China, in Croatia, ...

Multiple locations, including Little Rock

BipolarityDrugFrom 18 Years to 65 Years

Countries: United States, China, Croatia, ...
Sponsor: Bristol-Myers Squibb
Condition: Bipolarity

Drug study icon

RecruitingNCT07288567

KarXT for schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in Colombia, in Japan, ...

Multiple locations, including Anaheim

SchizophreniaDrugFrom 13 Years to 17 Years

Countries: United States, Colombia, Japan, ...
Sponsor: Bristol-Myers Squibb
Condition: Schizophrenia

Drug study icon

RecruitingNCT06882785

KarXT for schizophrenia

The registry lists this study as recruiting. Study locations are listed in Japan.

Multiple locations, including Kōnan

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: Japan
Sponsor: Bristol-Myers Squibb
Condition: Schizophrenia

Drug study icon

RecruitingNCT07065240

SPT-300 (GlyphAllo) for depression

The registry lists this study as recruiting. Study locations are listed in the United States, in Bulgaria, in Czechia, ...

Multiple locations, including Chino

DepressionDrugFrom 18 Years to 65 Years

Countries: United States, Bulgaria, Czechia, ...
Sponsor: Seaport Therapeutics
Condition: Depression

Drug study icon

RecruitingNCT06223880

Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

The registry lists this study as recruiting. Study locations are listed in the United States.

Multiple locations, including Bellflower

DepressionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Axsome Therapeutics, Inc.
Condition: Depression

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.